We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

143 hedge funds and large institutions have $261M invested in Vaxart in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 31 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 31

34% more capital invested

Capital invested by funds: $195M → $261M (+$65.7M)

11% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $24.7M

1.09% more ownership

Funds ownership: 27.38%28.48% (+1.1%)

10% less funds holding

Funds holding: 159143 (-16)

43% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 35

Holders
143
Holders Change
-16
Holders Change %
-10.06%
% of All Funds
2.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
59
Reduced
31
Closed
35
Calls
$27.4M
Puts
$24.7M
Net Calls
+$2.73M
Net Calls Change
-$1.81M

VXRT Hedge Fund Activity: Q2 2021 in Review

143 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2021, worth a combined $261M — up 34% from $195M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of VXRT and 20 opened new positions — a net loss of 15 holders — while 31 trimmed existing stakes and 59 added.

The largest buyer was BlackRock, adding an estimated $19.2M. The largest seller was State Street, cutting an estimated $7.33M.

  • 143 institutional investors held Vaxart (VXRT) as of Q2 2021, down from 159 in Q1 2021.
  • Funds reported $261M of Vaxart stock for Q2 2021, up 34% quarter-over-quarter.
  • 20 funds opened new Vaxart positions in Q2 2021 and 35 closed out, a net change of -15 holders.
  • The largest Vaxart buyer in Q2 2021 was BlackRock, an estimated $19.2M added.
  • The largest Vaxart seller in Q2 2021 was State Street, an estimated $7.33M sold.

Based on aggregated 13F filings for Q2 2021.